Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...
Analysts have recently evaluated Abbott Laboratories and provided 12-month price targets. The average target is $145.12, ...
Abbott Laboratories (NYSE:ABT) recently experienced a 20% price increase over the last quarter. This uptick coincides with several noteworthy developments, including Abbott's collaboration with ...
The stock's fall snapped a two-day winning streak.
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a ...
Abbott Laboratories (ABT) sees mixed momentum as shares dip after gains. Analysts highlight strong demand, low debt, and ...
Abbott Laboratories' (NYSE:ABT) stock is up by a considerable 21% over the past three months. Since the market ...
Highlights,Abbott Laboratories has experienced a significant increase in stock value over recent months.,The company's return ...
Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...
2d
Barchart on MSNIs Abbott Laboratories Stock Outperforming the Dow?North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops & manufactures a diversified line of healthcare ...
Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops & manufactures a diversified line of healthcare products. Valued at $239.4 billion by market cap, Abbott’s extensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results